Competitive Costs of Disclosure by Biotech IPOs

By R. Guo, Baruch Lev, Nan Zhou. 2004

335 citations recorded by the source corpus.

Subfields: Accounting, Economics and Econometrics

View Paper: https://www.semanticscholar.org/paper/7f8ac06258a4026fa65a11da43c93dc533c9e40e

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Accounting

In Economics and Econometrics

Citations in the corpus

Company reputation and the cost of equity capital (2014, neutral): “Following Coller and Yohn (1997), Leuz and Verrecchia (2000), and Guo et al. (2004), among others, we use the company’s prior year daily bid-ask spread to proxy for information asymmetry, and we partition the full sample into quintiles, with companies in Q1 (Q5) having the lowest (highest)…”
Corporate governance and strategic information on the internet (2011, background): “, 2003), greater stock liquidity (Healy et al., 1999; Guo et al., 2004) and obtaining larger volumes of funds (Marr and”
Explaining the Short- and Long-Term IPO Anomalies in the US by R&D (2006, neutral): “, patent protection) in the IPO prospectus (Guo et al., 2004).”
Narrative Disclosure and Earnings Performance: Evidence from R&D Disclosures (2014, neutral): “Nevertheless, it is difficult to determine whether narrative R&D disclosure provides good or bad news because such analysis requires a measure of investor expectations (Guo et al. 2004).”
The impacts of product market competition on the quantity and quality of voluntary disclosures (2010, background): “For example, Bhojraj et al. (2004) examine the disclosures on firms’ strategies to protect the existing customer base and plans to exploit emerging opportunities in electric utilities industry; Guo et al. (2004) examine the disclosures on product-related information in IPO prospectuses by biotech ”
Determinants of intellectual capital disclosure in prospectuses of initial public offerings (2008, methodology): “For example, product market competition may provide disincentives for voluntary disclosure (Guo et al., 2004).”
Disclosure of information on intellectual capital in Danish IPO prospectuses (2005, background): “However, its application is not limited to annual reporting, although it has also in been applied to IPO prospectuses by Cumby and Conrad (2001) as well as Guo et al. (2004) , who studied product-related IPO disclosure in biotechnology companies.”
A Cross-Disciplinary Exploration of Entrepreneurship Research (2007, background): “Complementing Hand’s (2005) work is the Guo et al. (2004) finding that IPO firms disclose information when there is patent protection, when the firm is in later stages of product development (competitors will be unlikely to gain technological parity), and when the firm has venture capital (VC)…”
The contents of assurance statements for sustainability reports and information asymmetry (2017, positive): “…at least one of the GRI main headings ‘sustainability’, ‘environment’, ‘employee’, ‘human rights’, ‘social’, or ‘responsibility’.6 In line with prior studies (Guo et al. 2004, Nekounam et al. 2012), we control for share turnover (Turnover), market value of common equity (Market value),…”
The Valuation of Biotech IPOs (2005, methodology): “We construct our development-stage indicator by adopting a procedure used in Guo, Lev, and Zhou (2004).”